• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简短报告:荧光利什曼原虫:在抗利什曼原虫药物测试中的应用

Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.

作者信息

Singh Neeloo, Dube Anuradha

机构信息

Division of Biochemistry and Division of Parasitology, Central Drug Research Institute, Lucknow, India.

出版信息

Am J Trop Med Hyg. 2004 Oct;71(4):400-2.

PMID:15516633
Abstract

Classic techniques for detecting the susceptibility of Leishmania to different drugs are time-consuming, laborious, and require the use of macrophages. The use of flow cytometry for monitoring Leishmania susceptibility to drugs is beginning to be implemented. Using green fluorescent protein (GFP), we have improved and simplified the screening procedure. We introduced a GFP marker into field strains of Leishmania causing kala-azar (visceral leishmaniasis) and explored the suitability of transgenic L. donovani promastigotes that constitutively express GFP in their cytoplasm as target cells for in vitro screening of anti-leishmanial drugs.

摘要

检测利什曼原虫对不同药物敏感性的经典技术耗时、费力,且需要使用巨噬细胞。利用流式细胞术监测利什曼原虫对药物的敏感性的方法已开始得到应用。我们利用绿色荧光蛋白(GFP)改进并简化了筛选程序。我们将GFP标记引入引起黑热病(内脏利什曼病)的利什曼原虫野外菌株中,并探索了在细胞质中组成性表达GFP的转基因杜氏利什曼原虫前鞭毛体作为抗利什曼原虫药物体外筛选靶细胞的适用性。

相似文献

1
Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.简短报告:荧光利什曼原虫:在抗利什曼原虫药物测试中的应用
Am J Trop Med Hyg. 2004 Oct;71(4):400-2.
2
Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.持续表达绿色荧光蛋白的转基因杜氏利什曼原虫临床分离株用于快速可靠的体外药物筛选。
J Antimicrob Chemother. 2009 Aug;64(2):370-4. doi: 10.1093/jac/dkp206. Epub 2009 Jun 12.
3
Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.细胞内寄生虫杀伤:流式细胞术和一氧化氮检测用于快速区分抗利什曼原虫活性和巨噬细胞激活。
J Immunol Methods. 2008 Apr 20;333(1-2):79-88. doi: 10.1016/j.jim.2008.01.004. Epub 2008 Feb 5.
4
Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate.使用5-氯甲基荧光素二乙酸酯通过流式细胞术测定利什曼原虫前鞭毛体内的细胞内非蛋白硫醇。
Exp Parasitol. 2009 Aug;122(4):299-305. doi: 10.1016/j.exppara.2009.04.012. Epub 2009 Apr 22.
5
Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.一种用于筛选抗利什曼原虫药物的半自动比色测定法的开发。
J Microbiol Methods. 2006 Jul;66(1):79-86. doi: 10.1016/j.mimet.2005.10.011. Epub 2005 Nov 28.
6
Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.米替福新通过线粒体功能障碍诱导抗亚砷酸盐的杜氏利什曼原虫前鞭毛体凋亡。
Exp Parasitol. 2007 May;116(1):1-13. doi: 10.1016/j.exppara.2006.10.007. Epub 2006 Dec 11.
7
Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.蛋白磷酸聚糖在印度杜氏利什曼原虫对葡糖酸锑钠敏感和耐药的临床分离株中存在差异表达。
Parasitology. 2007 Aug;134(Pt 9):1175-84. doi: 10.1017/S0031182007002569. Epub 2007 Mar 16.
8
Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis.利什曼病中细胞内一氧化氮的监测:其在内脏利什曼病患者中的适用性。
Cytometry A. 2011 Jan;79(1):35-45. doi: 10.1002/cyto.a.21001.
9
The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine.来自秘鲁和尼泊尔的利什曼原虫临床分离株对米替福新的敏感性。
Am J Trop Med Hyg. 2005 Aug;73(2):272-5.
10
Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.米替福新促进以γ干扰素为主导的抗利什曼原虫免疫反应。
J Immunol. 2009 Jun 1;182(11):7146-54. doi: 10.4049/jimmunol.0803859.

引用本文的文献

1
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.利什曼原虫属对抗两性霉素 B 和氟康唑的敏感性检测,使用 Sensititre™ YeastOne™ YO9 平台。
BMC Infect Dis. 2019 Jul 8;19(1):593. doi: 10.1186/s12879-019-4237-3.
2
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.针对三锥虫病(重点是利什曼病)的药物发现挑战。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):430-439. doi: 10.1016/j.ijpddr.2018.09.006. Epub 2018 Sep 28.
3
New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.
实验性内脏利什曼病的新见解:杜氏利什曼原虫毒力的实时体内成像
PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005924. doi: 10.1371/journal.pntd.0005924. eCollection 2017 Sep.
4
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?内脏利什曼病的治疗:我们拥有什么、我们需要什么以及如何提供治疗?
Int J Parasitol Drugs Drug Resist. 2012 Jan 28;2:11-9. doi: 10.1016/j.ijpddr.2012.01.003. eCollection 2012 Dec.
5
An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.一种使用转染红色荧光蛋白的亚马逊利什曼原虫进行的体外药物筛选替代试验。
Diagn Microbiol Infect Dis. 2013 Mar;75(3):282-91. doi: 10.1016/j.diagmicrobio.2012.11.018. Epub 2013 Jan 10.
6
Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.评估一株稳定表达 mCherry 荧光蛋白的利什曼原虫(Leishmania major)菌株,用于针对皮肤利什曼病的潜在药物和疫苗的体内和体外研究。
PLoS Negl Trop Dis. 2012;6(11):e1927. doi: 10.1371/journal.pntd.0001927. Epub 2012 Nov 29.
7
Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.利用体内和体外系统筛选表达绿色荧光蛋白的亚马逊利什曼原虫。
Korean J Parasitol. 2011 Dec;49(4):357-64. doi: 10.3347/kjp.2011.49.4.357. Epub 2011 Dec 16.
8
Bioinformatic Analysis of Leishmania donovani Long-Chain Fatty Acid-CoA Ligase as a Novel Drug Target.杜氏利什曼原虫长链脂肪酸辅酶A连接酶作为新型药物靶点的生物信息学分析
Mol Biol Int. 2011;2011:278051. doi: 10.4061/2011/278051. Epub 2011 Jul 19.
9
Visceral leishmaniasis: experimental models for drug discovery.内脏利什曼病:药物发现的实验模型。
Indian J Med Res. 2011 Jan;133(1):27-39.
10
In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis.针对内脏利什曼病的选择性喋呤还原酶抑制剂的计算机筛选、结构-活性关系和生物学评价。
Antimicrob Agents Chemother. 2011 Feb;55(2):659-66. doi: 10.1128/AAC.00436-10. Epub 2010 Nov 29.